NEW YORK, Sept. 24 – Alpha Therapeutic said it has received US Food and Drug Administration approval to use polymerase chain reaction technology to screen plasma donations for HIV-1 and hepatitis C.

The company, which made the announcement Friday, said it was the first company to receive such approval.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.